US$ 21.29
glp 1 sanofi Five Unexpected New Uses for GLP-1 Receptor Agonists Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists
Description
The TRIUMPH-Outcomes trial, beyond efficacy on clinical outcomes, will provide data on whether the drugs are safe, including in those with more advanced CKD (54)

There was no evidence of significant pulmonary aspiration, although the patient required additional oxygen in the postanesthesia care unit

Sehgal P, Lichtenstein GR, Khanna T, et al

Association of mildly reduced kidney function with cardiovascular disease: The Framingham heart study

Wadden TA, Chao AM, Machineni S, et al
